Evusheld Emergency Use Authorization Withdrawn

Upcoming Events

Pneumococcal Vaccine Update for Physicians and Clinicians – April 30

Please join us for a pneumococcal vaccine update webinar on Tuesday, April 30, noon - 1:00 p.m. and hear from Lynn Fisher, MD, family physician and Gretchen Homan, MD, pediatrician, who will provide updates impacting adult pneumococcal vaccine recommendations for adult and pediatric patients, respectively and Monica Pando, RN, VFC coordinator, who will discuss navigating these updates from a clinic perspective.

careLearning Informational Webinar - May 1

In this webinar you will gain practical knowledge of how the careLearning system will help you organize and manage your education. careLearning is non-profit member service of The Kansas Hospital Association and over 40 other state hospital associations.

KARQM Education Program - May 2

The Kansas Association of Risk and Quality Management was created to promote the delivery of quality health care and the practice of risk management in Kansas health care facilities. Membership includes risk and quality management professionals in health care facilities or health-related organizations.

Educational Webinar: How Do Your Hospital Finances Measure Up? – May 2

Join Healthworks and KHA for an educational session at 2:00 p.m. on May 2 to learn how to utilize QHis financial benchmarking tool effectively. Shannan Flach, vice president health care finance and reimbursement and Sally Othmer, vice president data and strategic analytics will be joined by Wes Garrison, founder, Databasically to walk through the tool including the easy-upload process, reviewing the QHi financial measures available and to demonstrating how to run and schedule reports.

Opioid Educational Webinar: Partnering to Increase Access to SUD Treatment – May 3

Please join us on May 3 to hear how hospitals and communities are partnering to increase access to substance use disorder treatment and harm reduction. The program has been approved for 1.0 contact hours of continuing nursing education and pending approval for 1.0 contact hours of continuing pharmacy education. There is no charge to attend as this program is funded through a grant from our partners at DCCCA.

Current Report Articles

‹‹ Back To List

Evusheld Emergency Use Authorization Withdrawn

(Feb. 3, 2023) – On Jan. 26, the Food and Drug Administration announced the agency has withdrawn the emergency use authorization for tixagevimab-cilgavimab (Evusheld) because it is not expected to be effective against the currently dominant XBB.1.5 Omicron subvariant. As a result, Evusheld is not authorized for use in the U.S. until further notice by the FDA. FDA told AstraZeneca it would make a determination about reinstating authorization of Evusheld if the prevalence of resistant variants in the United States is 90 percent or less on a sustained basis. For a list of currently recommended COVID treatment guidelines by the National Institutes of Health, see the NIH COVID-19 Treatment Guidelines.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News